Abstract
The older adult population in the U.S. (>75 years old) is growing rapidly with seniors living well into their 80s and 90s. Incidence of calcific valvular stenosis increases with age, and as a result, the prevalence of calcific valvular aortic stenosis (AS) is increasing. Elderly people with symptomatic AS are particularly vulnerable to mortality as well as to reduced quality of life and increased dependency. Trans-catheter aortic valve replacement (TAVR) has revolutionized the treatment options for those with AS, especially in older adults who were previously deemed non-surgical or high risk surgical candidates. Several reports have shown improvements in longevity, functional class and quality of life following TAVR in older adults. Surgical techniques for aortic valve replacement have also improved. This review will discuss clinical elements of AS and the dynamic field of interventional treatment options.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Ghaisas NK, Foley JB, O'Briain DS, et al. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. J Am Coll Cardiol. 2000;36:2257–62.
Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis Histological and immunohistochemical studies. Circulation. 1994;90:844–53.
•• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607. This is the landmark paper demonstrating the impact TAVR was going to have on managing patients with AS..
•• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98. This paper showed that TAVR was not just for non-surgical patients, but for high surgical risk patients as well..
Holmes Jr DR, Mack MJ. Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58:445–55.
Stephan PJ, Henry III AC, Hebeler Jr RF, et al. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol. 1997;79:166–72.
Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373:956–66.
Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation. 1979;59:679–88.
Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007;115:2856–64.
Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet. 1992;340:35–7.
Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:676–85.
Vasques F, Messori A, Lucenteforte E, Biancari F. Immediate and late outcome of patients aged 80 years and older undergoing isolated aortic valve replacement: a systematic review and meta-analysis of 48 studies. Am Heart J. 2012;163:477–85.
O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg. 2009;88:S23–42.
Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm issues and controversies. J Gerontol A Biol Sci Med Sci. 2007;62:731–7.
Cesari M, Kritchevsky SB, Penninx BWHJ, et al. Prognostic value of usual gait speed in well-functioning older people–results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2009;57:251–9.
• Afilalo J, Eisenberg MJ, Morin J-F, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010;56:1668–76. This analysis showed the power of a simple 6 minute walk test in predicting outcomes after cardiac surgery.
Cribier A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. First human case description. Circulation. 2002;106:3006–8.
Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198–204.
Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol. 2012, [Epub ahead of print].
Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–704.
Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253–69.
Généreux P, Head SJ, Van Mieghem NM et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 59:2317-2326.
Lefèvre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011;32(2):148–57.
• Rodés-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol. 2011;9:15–29. This is a comprehensive review of TAVR and includes descriptions of new devices in various stages of development.
•• Bagur R, Rodés-Cabau J, Dumont E, et al. Exercise capacity in patients with severe symptomatic aortic stenosis before and six months after transcatheter aortic valve implantation. Am J Cardiol. 2011;108:258–64. This study showed the impact TAVR can have on exercise capacity in older adults with AS treated with TAVR. They also point out that 20 % of those treated will not have an improvement in exercise capacity.
Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012;125:1102–9.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barker, C.M. Aortic Valve Surgery and Transcatheter Aortic Valve Replacement for the Very Old: Improved Interventional Therapeutic Options for Aortic Stenosis for Elderly. Curr Cardiovasc Risk Rep 6, 420–424 (2012). https://doi.org/10.1007/s12170-012-0264-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12170-012-0264-y